These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32631567)

  • 1. Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors.
    Silva TL; Dos Santos DA; de Jesus HCR; Brömme D; Fernandes JB; Paixão MW; Corrêa AG; Vieira PC
    Bioorg Med Chem; 2020 Aug; 28(15):115597. PubMed ID: 32631567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K.
    Law S; Panwar P; Li J; Aguda AH; Jamroz A; Guido RVC; Brömme D
    PLoS One; 2017; 12(10):e0186869. PubMed ID: 29088253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel selective proline-based peptidomimetics for human cathepsin K inhibition.
    Cardoso Prado Martins F; Dos Reis Rocho F; Bonatto V; Jatai Batista PH; Lameira J; Leitão A; Montanari CA
    Bioorg Med Chem Lett; 2024 Sep; 110():129887. PubMed ID: 39002936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity.
    Lemke C; Benýšek J; Brajtenbach D; Breuer C; Jílková A; Horn M; Buša M; Ulrychová L; Illies A; Kubatzky KF; Bartz U; Mareš M; Gütschow M
    J Med Chem; 2021 Sep; 64(18):13793-13806. PubMed ID: 34473502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dioxo-triazines as a novel series of cathepsin K inhibitors.
    Rankovic Z; Cai J; Fradera X; Dempster M; Mistry A; Mitchell A; Long C; Hamilton E; King A; Boucharens S; Jamieson C; Gillespie J; Cumming I; Uitdehaag J; van Zeeland M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1488-90. PubMed ID: 20153187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the discovery of cathepsin K inhibitors on bone resorption.
    Lu J; Wang M; Wang Z; Fu Z; Lu A; Zhang G
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):890-904. PubMed ID: 29723068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.
    Nizi E; Sferrazza A; Fabbrini D; Nardi V; Andreini M; Graziani R; Gennari N; Bresciani A; Paonessa G; Harper S
    Bioorg Med Chem Lett; 2018 May; 28(9):1540-1544. PubMed ID: 29615344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S.
    Galibert M; Wartenberg M; Lecaille F; Saidi A; Mavel S; Joulin-Giet A; Korkmaz B; Brömme D; Aucagne V; Delmas AF; Lalmanach G
    Eur J Med Chem; 2018 Jan; 144():201-210. PubMed ID: 29272750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
    Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
    Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected Activity of a Novel Kunitz-type Inhibitor: INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES.
    Smith D; Tikhonova IG; Jewhurst HL; Drysdale OC; Dvořák J; Robinson MW; Cwiklinski K; Dalton JP
    J Biol Chem; 2016 Sep; 291(37):19220-34. PubMed ID: 27422822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor.
    Sharma V; Panwar P; O'Donoghue AJ; Cui H; Guido RV; Craik CS; Brömme D
    Biochem J; 2015 Jan; 465(1):163-73. PubMed ID: 25279554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K.
    Mons E; Jansen IDC; Loboda J; van Doodewaerd BR; Hermans J; Verdoes M; van Boeckel CAA; van Veelen PA; Turk B; Turk D; Ovaa H
    J Am Chem Soc; 2019 Feb; 141(8):3507-3514. PubMed ID: 30689386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L.
    Dos Santos DA; Deobald AM; Cornelio VE; Ávila RMD; Cornea RC; Bernasconi GCR; Paixão MW; Vieira PC; Corrêa AG
    Bioorg Med Chem; 2017 Sep; 25(17):4620-4627. PubMed ID: 28720327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.
    Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S
    Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
    Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
    J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
    Rankovic Z; Cai J; Kerr J; Fradera X; Robinson J; Mistry A; Hamilton E; McGarry G; Andrews F; Caulfield W; Cumming I; Dempster M; Waller J; Scullion P; Martin I; Mitchell A; Long C; Baugh M; Westwood P; Kinghorn E; Bruin J; Hamilton W; Uitdehaag J; van Zeeland M; Potin D; Saniere L; Fouquet A; Chevallier F; Deronzier H; Dorleans C; Nicolai E
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1524-7. PubMed ID: 20149657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Site Mapping of Human Cathepsin F with Dipeptide Nitrile Inhibitors.
    Schmitz J; Furtmann N; Ponert M; Frizler M; Löser R; Bartz U; Bajorath J; Gütschow M
    ChemMedChem; 2015 Aug; 10(8):1365-77. PubMed ID: 26119278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead.
    Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P
    ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.